RCEL Avita Medical, Inc.
$16.71▲ +1.27%
Healthcare
Other
Volume 312.0K
Avg Volume (10D) 454.4K
Key Metrics & Fundamentals
Market Cap
$516.79M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.22 - 16.90
% vs 50 MA
38.14%
% vs 200 MA
157.41%
RSI-14
80.4
MACD Histogram
+0.2000
Beta (1Y vs SPY)
1.66
Free Cash Flow
-$3.61M
Gross Rev
$21.70M
Gross Profit
$17.77M
EBITDA
-$5.56M
COGS
$3.94M
Operating Exp
$24.62M
Operating Income
-$6.86M
EBIT
-$6.86M
Pretax Income
-$7.63M
Net Income
-$7.66M
EPS (Diluted)
-0.25
Price & Volume History
Loading chart…
Recent News
What AVITA Medical Holders Bought Into Before A 347% Run
Simply Wall St. · Oct 26, 2026 3:10 PM ET
AVITA Medical to Announce Third Quarter 2026 Financial Results
GlobeNewswire · Oct 20, 2026 4:10 PM ET
AVITA Medical (RCEL) Stock Sees Fair Value Lift After PermeaDerm Data And Q2 Beat
Simply Wall St. · Oct 1, 2026 11:09 AM ET
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
GlobeNewswire · Sep 2, 2026 4:10 PM ET
All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy
Zacks · Aug 31, 2026 12:00 PM ET
AVITA Medical (RCEL) Stock Fair Value Rises After PermeaDerm Data And Analyst Target Increases
Simply Wall St. · Aug 25, 2026 1:07 PM ET
Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?
Zacks · Aug 24, 2026 12:00 PM ET
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft
MarketBeat · Aug 19, 2026 8:02 AM ET
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
GlobeNewswire · Aug 18, 2026 7:45 AM ET
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%
MarketBeat · Aug 16, 2026 6:01 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See RCEL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.